EXPERIENCE: Semi-solid and liquid dosage forms can present unique challenges during formulation development, scale-up, or after long term storage. Since 1977, Dow’s sole focus has been on semi-solid and liquid product development. We are committed to delivering superior customer experience second to none, but just as importantly, we deliver results you can count on.
EXPERTISE: We understand and routinely solve issues with API solubility and compatibility with various excipients, chemical and physical stability, and API penetration to the target tissue to develop scalable products.
SUCCESS: We support the success of our clients. Almost one-third of all NDAs for prescription topical dermatological products approved by the FDA in the last seven years were developed at Dow. At Dow – Our Focus is on Your Success!
To learn more about working with Dow on your next semi-solid or liquid product development project, please contact us today.